nortriptyline has been researched along with Recrudescence in 53 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The investigators studied a patient with a nortriptyline HCI level of 1,205 ng/mL who had four generalized grand mal seizures, each lasting between 60 and 90 seconds that were immediately followed by hypotension requiring norepinephrine support." | 7.69 | Recurrent hypotension immediately after seizures in nortriptyline overdose. ( Bell, A; Gaynor, B; Lipper, B, 1994) |
| " A sustained remission rate of 50% over 2 years in patients with severe major depression who were treated with nortriptyline monotherapy after successful ECT is encouraging." | 5.69 | Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression. ( Birkenhäger, TK; Kamperman, AM; Pluijms, EM; Vinther, PT, 2023) |
| "Data are presented on the baseline characteristics and 2- to 3-year follow-up assessments of placebo-washout responders (PWRs) from a previously reported pharmacokinetically designed double-blind placebo-controlled trial of nortriptyline for major depressive disorder in 6- to 12-year-olds." | 5.07 | Baseline and 2- to 3-year follow-up characteristics of placebo-washout responders from the nortriptyline study of depressed 6- to 12-year-olds. ( Cooper, TB; Fox, LW; Garrity, K; Geller, B, 1992) |
| " Our studies have suggested that older patients appear to benefit as much, though perhaps more slowly, than mid-life patients from acute combined treatment (nortriptyline+interpersonal psychotherapy) of major depression." | 4.79 | Treatment of major depression in later life: a life cycle perspective. ( Reynolds, CF, 1997) |
| "Nortriptyline and VEN were equally effective in prolonging remission, although relapse rates after ECT are substantial despite intensive pharmacology." | 3.87 | Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. ( Cooper, T; Haskett, RF; Isenberg, K; McCall, WV; Mulsant, BH; Prudic, J; Rosenquist, PB; Sackeim, HA, 2013) |
| " The investigators studied a patient with a nortriptyline HCI level of 1,205 ng/mL who had four generalized grand mal seizures, each lasting between 60 and 90 seconds that were immediately followed by hypotension requiring norepinephrine support." | 3.69 | Recurrent hypotension immediately after seizures in nortriptyline overdose. ( Bell, A; Gaynor, B; Lipper, B, 1994) |
| "Patients with major depressive disorder and an indication for ECT received either nortriptyline or placebo during a bilateral ECT course." | 3.11 | Influence of adjuvant nortriptyline on the efficacy of electroconvulsive therapy: A randomized controlled trial and 1-year follow-up. ( Birkenhäger, TK; Hoogendijk, WJG; Kamperman, AM; Pluijms, EM; van den Broek, WW, 2022) |
| "Relapse was assessed with the 24-item Hamilton Rating Scale for Depression." | 2.74 | Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). ( Bailine, SH; Fink, M; Husain, MM; Kellner, CH; Knapp, RG; Mueller, M; Petrides, G; Rasmussen, KG; Rummans, TA; Sampson, SM, 2009) |
| "It suggests that successfully treating depression in PD leads to important, sustained improvements in these outcomes and that patients who improve on antidepressants are less likely to relapse than are patients who initially improve on placebo." | 2.74 | The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. ( Bienfait, K; Buyske, S; Dicke, A; Dobkin, RD; Gara, M; Marin, H; Mark, MH; Menza, M, 2009) |
| "Subjects had only recurrent, unipolar depression." | 2.70 | Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. ( Begley, A; Dew, MA; Frank, E; Houck, PR; Kupfer, DJ; Mazumdar, S; Mulsant, B; Reynolds, CF, 2001) |
| "The time to recurrence of a major depressive episode for all 3 active treatments was significantly better than for placebo." | 2.69 | Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. ( Cornes, C; Dew, MA; Frank, E; Houck, PR; Imber, SD; Kupfer, DJ; Mazumdar, S; Miller, MD; Perel, JM; Pollock, BG; Reynolds, CF; Stack, JA, 1999) |
| "These mothers are apprehensive about recurrence after later births." | 2.67 | Prevention of recurrent postpartum major depression. ( Wheeler, SB; Wisner, KL, 1994) |
| "Mean survival time without recurrence is 21." | 2.66 | Open-trial maintenance pharmacotherapy in late-life depression: survival analysis. ( Cornes, C; Frank, E; Imber, S; Kupfer, DJ; Morycz, RK; Perel, JM; Reynolds, CF; Thornton, J, 1989) |
| "Headaches are a common entity in the ambulatory population." | 2.40 | Diagnosis, prophylaxis, and treatment of headaches in the athlete. ( Kaplan, B; Swain, RA, 1997) |
| "Major depressive disorder is associated with increased cardiac mortality." | 1.36 | Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram. ( Bär, KJ; Höfels, S; Maier, W; Schuhmacher, A; Schulz, S; Voss, A; Yeragani, VK; Zobel, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (20.75) | 18.7374 |
| 1990's | 23 (43.40) | 18.2507 |
| 2000's | 13 (24.53) | 29.6817 |
| 2010's | 4 (7.55) | 24.3611 |
| 2020's | 2 (3.77) | 2.80 |
| Authors | Studies |
|---|---|
| Pluijms, EM | 2 |
| Kamperman, AM | 2 |
| Hoogendijk, WJG | 1 |
| van den Broek, WW | 1 |
| Birkenhäger, TK | 2 |
| Vinther, PT | 1 |
| van Eerd, EAM | 1 |
| van Schayck, OCP | 1 |
| Wesseling, G | 1 |
| Kotz, D | 1 |
| Rasmussen, KG | 1 |
| Mueller, M | 1 |
| Rummans, TA | 1 |
| Husain, MM | 1 |
| Petrides, G | 1 |
| Knapp, RG | 1 |
| Fink, M | 1 |
| Sampson, SM | 1 |
| Bailine, SH | 1 |
| Kellner, CH | 1 |
| Menza, M | 1 |
| Dobkin, RD | 1 |
| Marin, H | 1 |
| Mark, MH | 1 |
| Gara, M | 1 |
| Buyske, S | 1 |
| Bienfait, K | 1 |
| Dicke, A | 1 |
| Uher, R | 1 |
| Muthén, B | 1 |
| Souery, D | 1 |
| Mors, O | 1 |
| Jaracz, J | 1 |
| Placentino, A | 1 |
| Petrovic, A | 1 |
| Zobel, A | 2 |
| Henigsberg, N | 1 |
| Rietschel, M | 1 |
| Aitchison, KJ | 1 |
| Farmer, A | 1 |
| McGuffin, P | 1 |
| Bär, KJ | 1 |
| Schuhmacher, A | 1 |
| Höfels, S | 1 |
| Schulz, S | 1 |
| Voss, A | 1 |
| Yeragani, VK | 1 |
| Maier, W | 1 |
| Prudic, J | 2 |
| Haskett, RF | 2 |
| McCall, WV | 1 |
| Isenberg, K | 1 |
| Cooper, T | 1 |
| Rosenquist, PB | 1 |
| Mulsant, BH | 4 |
| Sackeim, HA | 2 |
| Morse, JQ | 1 |
| Pilkonis, PA | 1 |
| Houck, PR | 9 |
| Frank, E | 14 |
| Reynolds, CF | 19 |
| Pilhatsch, MK | 1 |
| Burghardt, R | 1 |
| Wandinger, KP | 1 |
| Bauer, M | 1 |
| Adli, M | 1 |
| Serra, M | 1 |
| Gastó, C | 1 |
| Navarro, V | 1 |
| Torres, X | 1 |
| Blanch, J | 1 |
| Masana, G | 1 |
| Dirks, AC | 1 |
| van Hyfte, DM | 1 |
| Bialos, D | 2 |
| Giller, E | 2 |
| Jatlow, P | 2 |
| Docherty, J | 1 |
| Harkness, L | 2 |
| Stack, JA | 3 |
| Paradis, CF | 1 |
| Anderson, B | 1 |
| Mayo, AL | 1 |
| Miller, MD | 10 |
| Rifai, AH | 4 |
| Perel, JM | 10 |
| Wisner, KL | 1 |
| Wheeler, SB | 1 |
| George, CJ | 3 |
| Mann, JJ | 2 |
| Cornes, C | 7 |
| Pollock, BG | 5 |
| Mazumdar, S | 12 |
| Lipper, B | 1 |
| Bell, A | 1 |
| Gaynor, B | 1 |
| Stokes, PE | 1 |
| Hambrecht, M | 1 |
| Dew, MA | 7 |
| Begley, A | 2 |
| Hall, M | 2 |
| Mulsant, B | 2 |
| Shear, MK | 1 |
| Kupfer, DJ | 8 |
| Pasternak, RE | 1 |
| Prigerson, H | 1 |
| Fasiczka, A | 1 |
| Byrne, S | 1 |
| Rothschild, AJ | 1 |
| Swain, RA | 1 |
| Kaplan, B | 1 |
| Begley, AE | 3 |
| Little, JT | 1 |
| Imber, SD | 2 |
| Miller, M | 2 |
| Flint, AJ | 3 |
| Rifat, SL | 3 |
| Alexopoulos, GS | 1 |
| Meyers, BS | 1 |
| Young, RC | 1 |
| Kalayam, B | 1 |
| Kakuma, T | 1 |
| Gabrielle, M | 1 |
| Sirey, JA | 1 |
| Hull, J | 1 |
| Bump, GM | 1 |
| Thase, ME | 1 |
| Pettinati, HM | 1 |
| Greenberg, RM | 1 |
| Crowe, RR | 1 |
| Cooper, TB | 4 |
| Szanto, K | 1 |
| Furlong, FW | 1 |
| Sellers, EM | 1 |
| Kapur, BM | 1 |
| Hansen, CE | 2 |
| Baastrup, PC | 1 |
| Hvidberg, EF | 2 |
| Seth, R | 1 |
| Jennings, AL | 1 |
| Bindman, J | 1 |
| Phillips, J | 1 |
| Bergmann, K | 1 |
| Morycz, RK | 2 |
| Geller, B | 1 |
| Fox, LW | 1 |
| Garrity, K | 1 |
| Scott, AI | 1 |
| Weeks, DJ | 1 |
| McDonald, CF | 1 |
| Hoch, CC | 1 |
| Buysse, DJ | 1 |
| Rifai, H | 1 |
| Imber, S | 2 |
| Thornton, J | 1 |
| Georgotas, A | 2 |
| McCue, RE | 2 |
| Nagachandran, N | 1 |
| Chang, I | 1 |
| Waldo, M | 1 |
| Simons, AD | 1 |
| Murphy, GE | 1 |
| Levine, JL | 1 |
| Wetzel, RD | 1 |
| Chisholm, DD | 1 |
| Kragh-Sorensen, P | 1 |
| Larsen, NE | 1 |
| Nasestoft, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Exploring Alterations of Central Autonomic Modulation in Patients With Bipolar Depression[NCT01213121] | Phase 4 | 60 participants (Anticipated) | Interventional | 2010-09-30 | Recruiting | ||
| Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen[NCT00626340] | Phase 4 | 18 participants (Actual) | Interventional | 1999-07-31 | Completed | ||
| A Prospective Study of Pregnant and Postpartum Women With and Without Mood Disorders[NCT03615794] | 400 participants (Anticipated) | Observational | 2017-10-01 | Recruiting | |||
| Adapting Marital Therapy in Older Adults With Depression[NCT00612807] | Phase 1/Phase 2 | 42 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| Randomised Controlled Trial of Electroconvulsive Therapy (ECT) With Pharmacotherapy or Pharmacotherapy Alone in Relapse Prevention of Depression[NCT00627887] | Phase 4 | 56 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Optimization of Electroconvulsive Therapy[NCT00045916] | Phase 4 | 340 participants (Actual) | Interventional | 2001-02-28 | Completed | ||
| Phase 1 Study: Evaluation of Three Continuation Therapies After Acute Electroconvusive Therapy (ECT) Concerning Efficacy and Cognition in Severly Depressed Patients[NCT00437385] | Phase 1 | 90 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| Relapse Prevention in Patients With a Major Depressive Episode Treated With Electroconvulsive Treatment Using a Fixed Dose Range of Escitalopram Compared to a Fixed Dose of Nortriptyline (DUAG-7) A Randomised Controlled 6 Month Double-blind Study[NCT00660062] | Phase 4 | 47 participants (Actual) | Interventional | 2009-08-31 | Terminated (stopped due to Slow inclusion) | ||
| Prolonging Remission in Depressed Elderly (PRIDE)[NCT01028508] | Phase 4 | 247 participants (Actual) | Interventional | 2010-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"This study was conducted at Yale University almost two decades ago. Our group at the University of Pennsylvania only has very basic information about this study. This includes the number of participants, which was 18, and the fact that no adverse events occurred. Staff members at the University of Pennsylvania do not have access to any additional study data. The contact person who initially entered this study protocol information is no longer at the University of Pennsylvania and we are unable to contact for additional information.~We only know that 18 participants completed, but as far as we know data was never analyzed for these 18 participants." (NCT00626340)
Timeframe: Healthy controls will undergo scans pre and post 3 weeks of estrogen treatment. Women with depression will undergo scans pre and post 6 weeks of treatment with estrogen alone, estrogen and fluoxetine, or fluoxetine alone
| Intervention | () |
|---|---|
| All Participants | 0 |
The DAS is a self-report measure of marital adjustment that includes questions about agreement on lifestyle and household decisions, level of conflict, level of cooperation, and affection. Scores range from 0 to 151, with higher scores representing better relationship functioning. (NCT00612807)
Timeframe: pre-treatment, monthly, post-treatment, 6 month follow-up
| Intervention | Score on DAS measure (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline assessment (Depressed spouse) | Post-test assessment (Depressed spouse) | Follow-up assessment (Depressed spouse) | Baseline assessment (Non-depressed spouse) | Post-test assessment (Non-depressed spouse) | Follow-up assessment (Non-depressed spouse) | |
| Semi-weekly Medication Management | 72.14 | 84.17 | 89.67 | 91.0 | 93.33 | 104.17 |
| Semi-weekly Medication Management + Weekly Marital Therapy | 84.43 | 92.27 | 91.07 | 88.29 | 97.57 | 98.31 |
The HDRS is a semi-structured interview administered by a trained independent evaluator, and used for rating the severity of depressive symptoms. Scores range from 0 to 50, with higher scores indicating greater severity of depression. (NCT00612807)
Timeframe: pre-treatment, monthly, post-treatment, 6 month follow-up
| Intervention | Score on HDRS (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline assessment (Depressed spouse) | Post-test assessment (Depressed spouse) | Follow-up assessment (Depressed spouse) | Baseline assessment (Non-depressed spouse) | Post-test assessment (Non-depressed spouse) | Follow-up assessment (Non-depressed spouse) | |
| Semi-weekly Medication Management | 17.86 | 5.00 | 9.17 | 5.14 | 5.33 | 3.83 |
| Semi-weekly Medication Management + Weekly Marital Therapy | 19.0 | 7.29 | 8.14 | 8.86 | 3.29 | 5.71 |
4 reviews available for nortriptyline and Recrudescence
| Article | Year |
|---|---|
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohex | 2013 |
A primary care perspective on management of acute and long-term depression.
Topics: Acute Disease; Adult; Aged; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combina | 1993 |
Treatment of major depression in later life: a life cycle perspective.
Topics: Aged; Antidepressive Agents; Anxiety; Bereavement; Clinical Trials as Topic; Combined Modality Thera | 1997 |
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; | 1997 |
32 trials available for nortriptyline and Recrudescence
| Article | Year |
|---|---|
Influence of adjuvant nortriptyline on the efficacy of electroconvulsive therapy: A randomized controlled trial and 1-year follow-up.
Topics: Depressive Disorder, Major; Electroconvulsive Therapy; Follow-Up Studies; Humans; Nortriptyline; Rec | 2022 |
Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; No | 2023 |
Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial.
Topics: Aged; Female; Humans; Male; Middle Aged; Nortriptyline; Patient Participation; Prevalence; Pulmonary | 2017 |
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
Topics: Adult; Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Drug Resi | 2009 |
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depression; Disability Evaluation; Double-Bli | 2009 |
Trajectories of change in depression severity during treatment with antidepressants.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Europe; Female; Follow-Up Studies; Ge | 2010 |
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohex | 2013 |
Impact of cluster C personality disorders on outcomes of acute and maintenance treatment in late-life depression.
Topics: Activities of Daily Living; Acute Disease; Aged; Antidepressive Agents, Tricyclic; Cluster Analysis; | 2005 |
[Maintenance electroconvulsive therapy in elderly psychotic unipolar depression].
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Electroconvulsive Therapy; Femal | 2006 |
Recurrence of depression after discontinuation of long-term amitriptyline treatment.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Female; Humans; Long-Term Care; Male; Middle Aged; | 1982 |
Prevention of recurrent postpartum major depression.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Nortriptyline; Odds Ratio; Pregnancy; Ps | 1994 |
Prevention of recurrent postpartum major depression.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Nortriptyline; Odds Ratio; Pregnancy; Ps | 1994 |
Prevention of recurrent postpartum major depression.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Nortriptyline; Odds Ratio; Pregnancy; Ps | 1994 |
Prevention of recurrent postpartum major depression.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Nortriptyline; Odds Ratio; Pregnancy; Ps | 1994 |
Treatment of consecutive episodes of major depression in the elderly.
Topics: Age Factors; Aged; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Middle Aged | 1994 |
High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression.
Topics: Age Factors; Age of Onset; Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disord | 1996 |
The posttreatment illness course of depression in bereaved elders. High relapse/recurrence rates.
Topics: Aged; Antidepressive Agents, Tricyclic; Bereavement; Combined Modality Therapy; Depressive Disorder; | 1997 |
How common is resistance to treatment in recurrent, nonpsychotic geriatric depression?
Topics: Academic Medical Centers; Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorde | 1998 |
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.
Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Dep | 1999 |
Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Com | 1999 |
Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Ag | 1999 |
The art of clinical management in pharmacologic trials with depressed elderly patients: lessons from the Pittsburgh Study of Maintenance Therapies in Late-Life Depression.
Topics: Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder, Major; Double | 1999 |
Executive dysfunction and long-term outcomes of geriatric depression.
Topics: Age Factors; Aged; Antidepressive Agents, Tricyclic; Cognition Disorders; Depressive Disorder; Femal | 2000 |
Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly.
Topics: Adrenergic Uptake Inhibitors; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Follow- | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; E | 2001 |
Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Dis | 2001 |
Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report.
Topics: Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Combined Modality Therapy; Depressive Disorde | 1992 |
Baseline and 2- to 3-year follow-up characteristics of placebo-washout responders from the nortriptyline study of depressed 6- to 12-year-olds.
Topics: Bipolar Disorder; Child; Depressive Disorder; Female; Follow-Up Studies; Humans; Longitudinal Studie | 1992 |
Sleep in late-life recurrent depression. Changes during early continuation therapy with nortriptyline.
Topics: Aged; Aged, 80 and over; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; H | 1991 |
Open-trial maintenance pharmacotherapy in late-life depression: survival analysis.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Female; Follow-Up Studies; Humans; Long-Term Ca | 1989 |
A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Nort | 1989 |
How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.
Topics: Age Factors; Aged; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nortri | 1988 |
Long-term amitriptyline in chronic depression.
Topics: Amitriptyline; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; | 1985 |
Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year.
Topics: Adolescent; Adult; Attitude; Behavior Therapy; Cognition; Combined Modality Therapy; Depressive Diso | 1986 |
Long-term treatment of endogenous depression with nortriptyline with control of plasma levels.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Blood Specimen Collection; Chromatography, Gas; Clinical | 1974 |
18 other studies available for nortriptyline and Recrudescence
| Article | Year |
|---|---|
Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depre | 2010 |
Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.
Topics: Atomoxetine Hydrochloride; Clozapine; Depressive Disorder, Major; Drug Therapy, Combination; Female; | 2006 |
Recurrent hyponatremia after substitution of citalopram with duloxetine.
Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depression; Duloxetine Hydrochlorid | 2007 |
Does recruitment method make a difference? Effects on protocol retention and treatment outcome in elderly depressed patients.
Topics: Adjustment Disorders; Aged; Bias; Combined Modality Therapy; Depressive Disorder; Female; Humans; Li | 1995 |
Hopelessness in suicide attempters after acute treatment of major depression in late life.
Topics: Age Factors; Aged; Depressive Disorder; Female; Follow-Up Studies; Geriatric Assessment; Humans; Mal | 1994 |
Recurrent hypotension immediately after seizures in nortriptyline overdose.
Topics: Biological Availability; Blood Pressure; Drug Overdose; Female; Heart; Humans; Hypotension; Midazola | 1994 |
[Toxic tricyclic drug plasma level caused by fluoxetine].
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressiv | 1995 |
Psychiatrists' responses to failure of maintenance therapy with antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Attitude of Health Personnel; Depressive Disorder; Do | 1997 |
Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients.
Topics: Age Factors; Age of Onset; Aged; Combined Modality Therapy; Depressive Disorder; Female; Humans; Lif | 1998 |
Maintenance treatment for recurrent depression in late life. A four-year outcome study.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Drug Therapy, Co | 2000 |
Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorde | 2001 |
Treatment outcome in suicidal vs. non-suicidal elderly patients.
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Depressive Disorder, Major; Female; Humans; Male; No | 2001 |
Amitriptyline blood levels and relapse.
Topics: Administration, Oral; Adult; Amitriptyline; Bipolar Disorder; Double-Blind Method; Female; Follow-Up | 1977 |
Therapeutic control of plasma concentrations and long-term effect of nortriptyline in recurrent affective disorders.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Depression; Female; Humans; Male; Middle Aged; Nortriptyli | 1976 |
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.
Topics: 1-Naphthylamine; Adult; Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Fem | 1992 |
Continuation electroconvulsive therapy: preliminary guidelines and an illustrative case report.
Topics: Aged; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Nor | 1991 |
Open-trial maintenance nortriptyline in geriatric depression: survival analysis and preliminary data on the use of REM latency as a predictor of recurrence.
Topics: Aged; Depressive Disorder; Humans; Nortriptyline; Recurrence; Sleep, REM | 1989 |
Change in serum antidepressant level at a constant dose of medication.
Topics: Depressive Disorder; Drug Tolerance; Female; Humans; Middle Aged; Nortriptyline; Recurrence | 1986 |